Related Experiment Video
Updated: Jun 2, 2026
Isolation and Immortalization of Patient-derived Cell Lines from Muscle Biopsy for Disease Modeling
Published on: January 18, 2015
The muscular dystrophies: distinct pathogenic mechanisms invite novel therapeutic approaches
Zarife Sahenk1, Jerry R Mendell
1The Research Institute at Nationwide Children's Hospital, Departments of Pediatrics and Neurology, Ohio State University, 700 Children's Drive, Room WA3024, Columbus, OH 43205, USA. zarife.sahenk@nationwidechildrens.org
Abstract:
Over the past decade, the enigmatic pathogenic mechanisms of the most common forms of muscular dystrophy have been defined. In this report, the molecular defects for each of these disorders are fully described, demonstrating the potential for therapeutic intervention. In facioscapulohumeral muscular dystrophy, recent findings implicate a stabilized DUX4 transcript within the contracted D4Z4 repeats, opening the door for an RNA interference treatment strategy. In the myotonic dystrophies (dystrophica myotonia [DM]), two variants of the disease (DM1 and DM2) are caused by unrelated genes yet manifest overlapping phenotypes. The common mechanism is a splicing disorder related to RNA toxicity. Duchenne muscular dystrophy is the most common childhood form of muscular dystrophy. In many ways, the molecular gene defects are the most traditional. Gene repair strategies have advanced to the level of clinical testing, and we hope they will provide relief for this most devastating form of muscular dystrophy.
Insights
Recent advances define muscular dystrophy mechanisms, revealing molecular defects and therapeutic targets. Strategies include RNA interference for facioscapulohumeral muscular dystrophy and gene repair for Duchenne muscular dystrophy.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Muscular dystrophies are common genetic disorders with complex pathogenic mechanisms.
- Understanding molecular defects is crucial for developing effective treatments.
Purpose of the Study:
- To describe the molecular defects in common forms of muscular dystrophy.
- To highlight potential therapeutic interventions based on defined pathogenic mechanisms.
Main Methods:
- Review of recent findings on molecular pathogenesis.
- Description of genetic and molecular defects in specific muscular dystrophies.
Main Results:
- Facioscapulohumeral muscular dystrophy: Stabilized DUX4 transcript linked to D4Z4 repeats suggests RNA interference therapy.
- Myotonic dystrophies (DM1, DM2): Unrelated genes cause overlapping phenotypes via RNA toxicity and splicing defects.
- Duchenne muscular dystrophy: Traditional molecular defects are well-defined, with gene repair strategies in clinical trials.
Conclusions:
- Molecular insights into muscular dystrophies pave the way for targeted therapies.
- RNA interference and gene repair represent promising treatment avenues for debilitating muscular dystrophies.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:22Myasthenia Gravis ll: Pathophysiology
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
01:29Pharmacogenomics: Identification of New Drug Targets
01:13Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...